icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
wevBGGQHq97xnXwP